Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03912818
Title Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford Cancer Institute Palo Alto Palo Alto California 94304 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field